Edition:
United States

CASI Pharmaceuticals Inc (CASI.OQ)

CASI.OQ on NASDAQ Stock Exchange Capital Market

6.28USD
22 Jun 2018
Change (% chg)

$0.57 (+9.98%)
Prev Close
$5.71
Open
$5.66
Day's High
$6.39
Day's Low
$5.16
Volume
4,091,423
Avg. Vol
201,288
52-wk High
$8.40
52-wk Low
$0.95

Latest Key Developments (Source: Significant Developments)

CASI Pharmaceuticals Announces $50 Million Private Placement
Tuesday, 20 Mar 2018 09:29am EDT 

March 20 (Reuters) - Casi Pharmaceuticals Inc ::CASI PHARMACEUTICALS ANNOUNCES $50 MILLION PRIVATE PLACEMENT TO PREPARE COMPANY FOR COMMERCIALIZATION IN CHINA.CASI PHARMACEUTICALS INC - ‍ON MARCH 19, 2018, CONSOLIDATED CLOSING BID PRICE PER SHARE OF COMMON STOCK WAS $3.19​.CASI PHARMACEUTICALS - ENTERED INTO DEFINITIVE SECURITIES PURCHASE AGREEMENTS PURSUANT TO WHICH CO WILL ISSUE 15.4 MILLION SHARES OF COMMON STOCK.  Full Article

CASI Pharma Board Approves Appointment Of Wei-Wu He As Executive Chairman
Friday, 9 Feb 2018 04:41pm EST 

Feb 9 (Reuters) - Casi Pharmaceuticals Inc ::CASI PHARMACEUTICALS - ON FEB 7, BOARD APPROVED APPOINTMENT OF WEI-WU HE, CURRENT CHAIRMAN OF BOARD, AS EXECUTIVE CHAIRMAN - SEC FILING.  Full Article

Casi Pharmaceuticals Files For Stock Shelf Of Upto $100 Million
Wednesday, 13 Dec 2017 05:35pm EST 

Dec 13 (Reuters) - Casi Pharmaceuticals Inc ::CASI PHARMACEUTICALS INC FILES FOR STOCK SHELF OF UPTO $100 MILLION - SEC FILING.  Full Article

Casi pharmaceuticals Q3 loss per share $0.03
Tuesday, 14 Nov 2017 07:00am EST 

Nov 14 (Reuters) - Casi Pharmaceuticals Inc :Casi Pharmaceuticals reports third quarter 2017 financial results.Q3 loss per share $0.03.As of September 30, 2017, Casi had cash and cash equivalents of approximately $21.6 million​.  Full Article

CASI provides pipeline development update
Thursday, 7 Sep 2017 07:00am EDT 

Sept 7 (Reuters) - CASI Pharmaceuticals Inc :CASI provides pipeline development update.CASI Pharmaceuticals Inc- CFDA has granted priority review for co's import drug registration clinical trial application for EVOMELA for injection.  Full Article

Casi Pharmaceuticals reports Q2 loss per share $0.04
Monday, 14 Aug 2017 07:00am EDT 

Aug 14 (Reuters) - Casi Pharmaceuticals Inc :Casi Pharmaceuticals reports second quarter 2017 financial results.Q2 loss per share $0.04.  Full Article

Casi Pharmaceuticals reports Q1 loss per share $0.03
Monday, 15 May 2017 07:00am EDT 

May 15 (Reuters) - Casi Pharmaceuticals Inc :Casi Pharmaceuticals reports first quarter 2017 financial results.Q1 loss per share $0.03.Casi Pharmaceuticals Inc - as of March 31, 2017, Casi had cash and cash equivalents of $25.5 million.  Full Article

Casi Pharmaceuticals reports Q4 loss per share $0.05
Friday, 31 Mar 2017 07:00am EDT 

Casi Pharmaceuticals Inc : CASI Pharmaceuticals reports 2016 fourth quarter and full year financial results .Q4 loss per share $0.05.  Full Article

Casi Pharmaceuticals says up to 28.9 mln shares of co's common stock may be offered for sale by selling stockholders
Friday, 2 Dec 2016 04:48pm EST 

Casi Pharmaceuticals Inc :Says up to 28.9 million shares of co's common stock may be offered for sale by selling stockholders - SEC filing.  Full Article

Casi Pharmaceuticals reports third quarter 2016 results
Monday, 14 Nov 2016 07:00am EST 

Casi Pharmaceuticals Inc : Casi Pharmaceuticals reports third quarter 2016 financial results .Q3 loss per share $0.03.  Full Article

BRIEF-CASI Pharmaceuticals Reports Q1 Loss Per Share Of $0.05

* CASI PHARMACEUTICALS ANNOUNCES FIRST QUARTER 2018 FINANCIAL AND BUSINESS RESULTS